CHANGE-IN-CONTROL AGREEMENTChange-in-Control Agreement • August 7th, 2003 • Invitrogen Corp • Biological products, (no disgnostic substances) • Delaware
AGREEMENT by and between INVITROGEN CORPORATION, a Delaware Corporation (the “Company”), and Gregory T. Lucier (the “Executive”), dated as of the 26th day of May 2003.
INDEMNIFICATION AGREEMENTIndemnification Agreement • August 7th, 2003 • Invitrogen Corp • Biological products, (no disgnostic substances) • Delaware
This Indemnification Agreement made and entered into this 26th day of May 2003 (“Agreement”), by and between Invitrogen Corporation, a Delaware corporation (together with any successor or successors and predecessor or predecessors thereto, the “Company”) and Gregory T. Lucier (“Indemnitee”).
EMPLOYMENT AGREEMENTEmployment Agreement • August 7th, 2003 • Invitrogen Corp • Biological products, (no disgnostic substances) • California
This Employment Agreement (the “Agreement”) is made and entered into by and between Invitrogen Corporation (along with its successors and assigns, the “Company”) and Gregory T. Lucier (the “Executive”) to be effective as of May 26, 2003.
ASSET PURCHASE AGREEMENT BY AND BETWEEN GENICON SCIENCES CORPORATION AND INVITROGEN CORPORATION JUNE 27, 2003Asset Purchase Agreement • August 7th, 2003 • Invitrogen Corp • Biological products, (no disgnostic substances) • California
This ASSET PURCHASE AGREEMENT (the “Agreement”) is entered into as of June 27, 2003, by and between Genicon Sciences Corporation, a California Corporation (“Seller”), and Invitrogen Corporation., a Delaware corporation (the “Buyer”). Seller and the Buyer are referred to herein individually as a “Party” and collectively as the “Parties.”
AMENDMENT TO EXECUTIVE EMPLOYMENT AND SEVERANCE AGREEMENTExecutive Employment and Severance Agreement • August 7th, 2003 • Invitrogen Corp • Biological products, (no disgnostic substances)
This amendment to the Executive Employment and Severance Agreement (the “Agreement”) that was made effective as of December 5, 2002, by and between Invitrogen Corporation (“Company”) and James R. Glynn (“Executive”) is entered into by such parties as of June 27, 2003. All capitalized terms used herein shall have the meaning ascribed thereto in the Agreement.
